Skip Navigation

Strengthening the evidence for maternal and child health programs

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 4 (4 total).

Children's Hospital of the District of Columbia. 1970. Symposium on services for children with heart disease: Children's Hospital of the District of Columbia—Commemorating its 100th anniversary. [Washington, DC: Children's Hospital of the District of Columbia?], 116 pp.

Annotation: The purpose of this conference was to assess present and past services for children with heart disease and to make recommendations regarding future goals to the Maternal and Child Health Service. Pediatric heart disease, its incidence, prevalence, mortality, and cost were discussed. Medical recommendations for future systems of care were also discussed, addressing congenital heart disease, rheumatic fever, regional specialty centers and catheterization laboratory standards. Manpower needs for surgeons, nurses, social service workers, and paramedical personnel were discussed. The administrative issues of regional, national, and state systems of care in the future were discussed as well. [Funded by the Maternal and Child Health Service]

Keywords: Children, Emergency medical technicians, Employment, Geographic factors, Heart catheterization, Heart diseases, Nurses, Rheumatic fever, Social workers, Surgeons

Pryor R, ed. 1966. Heart disease in children: Training program in cardiology: Proceedings—Denver, Colorado, December 3-6, 1962. Washington, DC: U.S. Department of Health, Education, and Welfare, Public Health Service, Heart Disease Control Program, 74 pp. (Public Health Service publication: no. 1374)

Annotation: These conference proceedings discuss the anatomy of congenital and acquired heart disease in children, the physiology of the cardiovascular system, epidemiology of congenital and rheumatic heart disease, the importance of history, techniques in physical diagnosis, the contribution of the laboratory to diagnosis in heart disease, the rheumatic fever diagnostic service, psychological aspects of heart disease, attitude and activity in the therapy of rheumatic fever, medical therapy in congenital heart disease, general aspects of congenital anomalies in children, surgery in heart disease, role of the field nurse and public health services in the care of heart diseases, and the role of the medical social worker.

Keywords: Children, Congenital abnormalities, Congenital heart defects, Diagnosis, Epidemiology, Heart diseases, Heart surgery, History, Home care services, Physiology, Psychology, Public health services, Rheumatic heart disease, Social workers

Lawrence EM. 1961. Vocational counseling for children with heart disease or a history of rheumatic fever: A pilot study. New York, NY: American Heart Association, 246 pp.

Wolff G. 1948. Childhood mortality from rheumatic fever and heart diseases. [Washington, DC]: U.S. Children's Bureau, 63 pp.

Annotation: This study of differential mortality from rheumatic fever and heart diseases in childhood discusses and provides statistics regarding their relative importance among other leading causes of death, age differential, race and socioeconomic differential, sex differential, and geographic variations. [Funded by the Maternal and Child Health Bureau]

Contact: Maternal and Child Health Library at Georgetown University, Box 571272, Washington, DC 20057-1272, Telephone: (202) 784-9770 E-mail: mchgroup@georgetown.edu Web Site: https://www.mchlibrary.org Available from the website.

Keywords: Age factors, Cause of death, Child mortality, Children, Geographic factors, Heart diseases, Racial factors, Rheumatic fever, Sex factors, Socioeconomic factors, Statistics

   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.